A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
French/Swiss crime network smashed
A major cross-border criminal network targeting Switzerland has been dismantled following a joint investigation by French and Swiss authorities.
Zurich commuters face transport upheaval
More than 800,000 people rely on Zurich’s public transport every day, and from today, many of them will be navigating unfamiliar routes.
Small relaxation for cross-border school students
The debate over cross-border students in Geneva schools took another turn in the Grand Council.
SSR SRG may return to FM
Switzerland’s transition to DAB radio is hitting some significant hurdles.
Geneva law on right-to-buy faces vote
In Geneva, a long-standing restriction on tenants buying the apartments they live in has been significantly loosened.
Geneva SPA under investigation
Geneva’s Cantonal Service for Consumer and Veterinary Affairs has opened an investigation into the Geneva Society for the Protection of Animals following complaints from former employees.
